Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate

Karen Nieto; Margit Weghofer; Peter Sehr; Mirko Ritter; Sebastian Sedlmeier; Balasubramanyam Karanam; Hanna Seitz; Martin Müller; Markus Kellner; Markus Hörer; Uwe Michaelis; Richard B. S. Roden; Lutz Gissmann; Jürgen A. Kleinschmidt

doi:10.1371/journal.pone.0039741

Loading metrics

Open Access

Peer-reviewed

Research Article

Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate

Karen Nieto ,

* E-mail: k.nieto@dkfz.de

Affiliation Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany
⨯
Margit Weghofer,

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Peter Sehr,

Affiliation Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
⨯
Mirko Ritter,

Current address: Roche Diagnostics GmbH, Penzberg, Germany

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Sebastian Sedlmeier,

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Balasubramanyam Karanam,

Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America
⨯
Hanna Seitz,

Affiliation Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany
⨯
Martin Müller,

Affiliation Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany
⨯
Markus Kellner,

Current address: GE Healthcare, Fast Trak Services, Munich, Germany

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Markus Hörer,

Current address: Rentschler Biotechnologie GmbH, Laupheim, Germany

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Uwe Michaelis,

Affiliation MediGene AG, Planegg/Martinsried, Germany
⨯
Richard B. S. Roden,

Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America
⨯
Lutz Gissmann,

Affiliation Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany
⨯
Jürgen A. Kleinschmidt

Affiliation Research Program Infection and Cancer, German Cancer Research Center, Heidelberg, Germany
⨯

Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate

Karen Nieto,
Margit Weghofer,
Peter Sehr,
Mirko Ritter,
Sebastian Sedlmeier,
Balasubramanyam Karanam,
Hanna Seitz,
Martin Müller,
Markus Kellner,
Markus Hörer

Published: June 27, 2012
https://doi.org/10.1371/journal.pone.0039741

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
HPV-16
Is the Subject Area "HPV-16" applicable to this article?

Thanks for your feedback.
Viral packaging
Is the Subject Area "Viral packaging" applicable to this article?

Thanks for your feedback.
HPV-31
Is the Subject Area "HPV-31" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Immunologic adjuvants
Is the Subject Area "Immunologic adjuvants" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.